Fortum Oyj (0HAH)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 23.06 |
|---|---|
| 52-week range | 16.98 – 25.82 |
| Return, 1 month / 3 months | −3.3% / +12.5% |
| Return, 1 year / 3 years | +29.0% / +145.8% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 32.5% |
| Worst drawdown (1 year) | -15.1% |
| Average daily value traded | 7.99M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fortum Oyj is a Finnish energy company based in Espoo. It produces and sells electricity and heat, operating power plants that include nuclear, hydroelectric and combined heat and power facilities. Its customers include households, businesses and industrial users, mainly in the Nordic countries and the Baltic region, and it also provides electricity retail and district heating services. The company additionally offers energy-related services and operates in electricity markets across northern Europe.
The shares are listed on the London Exchange in UK under the code 0HAH, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fortum Oyj (0HAH) trades on the London Exchange in UK. It last closed at EUR 23.06 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 324 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.0% and over the last three months it rose 12.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.4% | ||
| From 52-week high | -5.9% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.5% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | 33.4% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.1% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 7.99M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −3.3% |
| 3 months | +12.5% |
| 6 months | +5.3% |
| 1 year | +29.0% |
| 3 years | +145.8% |
| 5 years | +8.5% |
Signals
| 50-day / 200-day average | 22.50 / 20.89 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2025 | EUR 0.5000 |
| 1 Oct 2024 | EUR 0.5700 |
| 26 Mar 2024 | EUR 0.5800 |
| 29 Sep 2023 | EUR 0.4500 |
| 14 Apr 2023 | EUR 0.4600 |
| 29 Mar 2022 | EUR 1.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.